BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16760222)

  • 1. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
    Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
    Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.
    Bellanné-Chantelot C; Carette C; Riveline JP; Valéro R; Gautier JF; Larger E; Reznik Y; Ducluzeau PH; Sola A; Hartemann-Heurtier A; Lecomte P; Chaillous L; Laloi-Michelin M; Wilhem JM; Cuny P; Duron F; Guerci B; Jeandidier N; Mosnier-Pudar H; Assayag M; Dubois-Laforgue D; Velho G; Timsit J
    Diabetes; 2008 Feb; 57(2):503-8. PubMed ID: 18003757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
    Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
    Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype.
    Cappelli A; Tumini S; Consoli A; Carinci S; Piersanti C; Ruggiero G; Simonella G; Soletti F; Staffolani P; Pianese L
    Diabetes Res Clin Pract; 2009 Mar; 83(3):e72-4. PubMed ID: 19150152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study).
    Eide SA; Raeder H; Johansson S; Midthjell K; Søvik O; Njølstad PR; Molven A
    Diabet Med; 2008 Jul; 25(7):775-81. PubMed ID: 18513305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young.
    Beijers HJ; Losekoot M; Odink RJ; Bravenboer B
    Diabet Med; 2009 Nov; 26(11):1172-4. PubMed ID: 19929997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
    Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
    Karlsson E; Shaat N; Groop L
    Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for haploinsufficiency of the human HNF1alpha gene revealed by functional characterization of MODY3-associated mutations.
    Thomas H; Badenberg B; Bulman M; Lemm I; Lausen J; Kind L; Roosen S; Ellard S; Hattersley AT; Ryffel GU
    Biol Chem; 2002 Nov; 383(11):1691-700. PubMed ID: 12530534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Hegele RA
    Int J Obes (Lond); 2006 Mar; 30(3):484-91. PubMed ID: 16276364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of four novel mutations in the HNF-1A gene in Chinese early-onset and/or multiplex diabetes pedigrees.
    Yang Z; Wu SH; Zheng TS; Lu HJ; Xiang KS
    Chin Med J (Engl); 2006 Jul; 119(13):1072-8. PubMed ID: 16834925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype of a patient with a de novo mutation in the hepatocyte nuclear factor 1beta/maturity-onset diabetes of the young type 5 gene.
    Mayer C; Böttcher Y; Kovacs P; Halbritter J; Stumvoll M
    Metabolism; 2008 Mar; 57(3):416-20. PubMed ID: 18249217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
    Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds.
    Siggaard C; Christensen JH; Corydon TJ; Rittig S; Robertson GL; Gregersen N; Bolund L; Pedersen EB
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):207-16. PubMed ID: 16060916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
    Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
    Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.